Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 306 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. New version filed on ClinicalTrials.gov
  3. 48 versions Re-verified since Sep 21, 2024, no change to tracked fieldsv257-v304
Researchers plan to study the fat-rich particles, called lipoproteins, which circulate in the blood. This study is designed to improve understanding of normal, as well as abnormal, lipoprotein metabolism and the role it plays in the development of hardening of the arteries (atherosclerosis). Patients participating in this study will receive injections of lipoproteins or apolipoproteins (the protein component of lipoproteins) that have been isolated and purified. These lipoproteins will be labeled with small amounts of radioactive material and sterilized before they are injected into the patient. Patients participating in the study will be required to have blood samples taken, and provide urine samples throughout the course of the study. In addition, patient will be required to follow a specially formulated diet. Patients will be weighed throughout the course of the study.
Trial Details
NCT Number NCT00001154
Lead Sponsor National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)
Hypolipoproteinemia, Hypercholesterolemia, Dyslipidemia, Hyperlipidemia
Related terms Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, Hypoalphalipoproteinemias, Hypolipoproteinemias
Enrollment 759 participants
Start Date
Updated on ClinicalTrials.gov